In a study of 58 Indian patients with advanced breast cancer (mixed pre- and postmenopausal), Tulsyan et al. [36] reported an association between CYP3A5 rs776746 and complete or partial response to neo-adjuvant taxane treatment. The gene discussed is CYP3A5; the disease is breast cancer.